通过光谱洞察和多模式方法探测蛋白质聚合:对抗神经退行性疾病的综合性审查
Sania Bashir1, Ayesha Aiman2, Anis Ahmad Chaudhary3
1Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India.
Heliyon
|May 1, 2024
概括
蛋白质错误折叠和聚合是神经退行性疾病的标志,阻碍了药物设计. 生物物理技术为这些蛋白质结构和通路提供了洞察力,有助于治疗开发.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 结构生物学 结构生物学
背景情况:
- 异常的蛋白质错折导致聚合和纤维化,这是神经退行性疾病的特征.
- 无序,错误折叠和聚合的蛋白质在药物设计中提出了重大挑战.
- 了解蛋白质聚合物的结构变化对于神经退行性疾病研究至关重要.
研究的目的:
- 审查已建立的生物物理技术,用于蛋白质聚合的结构分析.
- 阐明神经退行性疾病中涉及的形状变化和途径.
- 推进对神经退行性疾病机制的理解,并为治疗策略提供信息.
主要方法:
- 使用各种生物物理技术工具包来分析蛋白质聚合物.
- 采用形态学和非形态学方法进行结构研究.
- 包含用于聚合动力学的 thioflavin T (ThT) 测定和用于二次结构分析的循环二元化 (CD) 谱学.
主要成果:
- 生物物理技术共同使蛋白质聚合物性质的全面解成为可能.
- 介质蛋白质聚合物的结构研究揭示了形状变化和路径.
- 该综述总结了蛋白质聚合结构分析的关键技术.
结论:
- 多方面的生物物理方法对于理解神经退行性疾病机制至关重要.
- 蛋白质聚合物的详细结构分析为潜在的治疗策略提供了信息.
- 这一综述为进一步研究蛋白质聚合和神经退行提供了基础.
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468


